Antibiotic release from a carrier can be employed to reduce the frequency of administration or prolong efficacy. In this work, we prepared silica nanoparticles loaded with gentamicin through different synthetis routes (entrapment, adsorption, covalent bonding and Layer-by-Layer (LbL) techniques). The nanocarriers physical-chemical properties were characterised and antibiotic release from the nanocarriers was monitored. The nanoparticles prepared entrapping gentamicin gave the highest drug load but completed the release over a period of 4 hours. No significant differences in antibiotic load were noticed between absorption or binding of gentamicin onto the silica nanoparticles surface; moreover the release of the drug occurred over 2 days. The nanoparticles coated with gentamicin through LbL technique released the antibiotic for 3 weeks. This work demonstrates that silica nanoparticles can be employed as antibiotic carriers providing a continuous release of antibiotic over a period that can be tuned through the choice of preparation method.
Adsorption of gentamicin onto the silica nanocarriers
Gentamicin sulphate (50 mg) was dissolved in 100 ml of MES buffer (0.1 M, pH 6). This solution was used to disperse the different nanoparticles (250 mg). The suspension was kept under vigorous stirring for 24 hours. The adsorbed nanoparticles were recovered by centrifuging at 3256 g for 10 min (LE-80K Ultracentrifuge, Beckman Coulter, UK) at room temperature. Then the nanoparticles were washed three times with methanol and dried on a watch glass over night at room temperature.
Layer-by-layer deposition of gentamicin on silica nanocarriers
Dipping solutions were prepared in 100mM sodium acetate buffer pH = 5; alginate and chitosan were prepared at 2 mg/ml whilst gentamicin was prepared at 10 mg/ml. About 250 mg of amino functionalised nanoparticles (SiO2-NH2) were dispersed in 25 ml of alginate solution and vortexed for 10 min. Particles were separated through centrifugation at 3256 g for 10 min. The supernatant was removed and the particles washed through redispersion in fresh acetate buffer pH = 5 and centrifuged at 3256 g for 10 min (LE-80K Ultracentrifuge, Beckman Coulter, UK). After discharging the supernatant, another layer was deposited dispersing the particles in gentamicin solution (25 ml) and vortexing for 10 min. The centrifugation/washing protocol was repeated and then again the particles were vortexed in alginate for 10 min. After repeating the centrifugation/washing protocol the particles were dispersed in chitosan for 10 min with vortexing. Finally, the particles were centrifuged, washed with clean buffer, deposited onto a glass watch and left to dry in a fume hood.
Silica-antibiotic nanocarriers characterisation

Transmission electron microscopy (TEM)
Size and shape of the conjugates was determined through transmission electron microscopy (TEM); 4 µl droplet of conjugates suspension were deposited on a plain carbon-coated copper TEM grid, water was evaporated under ambient laboratory conditions for several hours. Bright field TEM images were obtained using a TEM (Philips CM12, FEI Ltd, UK) operating at 80kV fitted with an X-ray microanalysis detector (EM-400 Detecting Unit, EDAX UK) utilising EDAX's Genesis software. Images (magnification of the images was x 100000) were recorded using a SIS MegaView III digital camera (SIS Analytical, Germany) and analysed with ImageJ; the diameter of at least 100 particles was determined for each type of nanoparticles.
Thermogravimetric analysis (TGA)
Thermogravimetric analysis (TGA) was performed using a Stanton Redcroft, STA-780; data were recorded from 25 to 600 °C with a constant heating rate of 10 °C min-1.
Brunauer-Emmett-Teller (BET)
Nitrogen adsorption-desorption isotherms were used to determine porosity and specific surface area of the silica nanoparticles. Isotherms at 77 K were obtained using BET Analyser, NOVA-e™ Series (Quantochrome Instruments, USA). Before starting the adsorption measurements, all silica samples were degassed under vacuum at 80° C for 4 h. The BET surface was calculated through the MultiPoint BET model using the instrument software. The total pore volume was determined for pores with a radius less than 405 Å at P/Po = 0.97 by the instrument software.
Zeta potential
Approximately 2 mg sample were dispersed in 1 ml of buffer solution at the chosen pH. The suspension was vortexed and transferred to a capillary cell. The zeta potential was measured immediately using Zetasizer ZEN 3600, Nano Series (Malvern, UK). For pH = 4 and 5, an acetic buffers (0.1 M) were prepared, whereas phosphate buffer (0.1 M) was employed for pH = 7. The highest pH value was achieved with a glycine buffer pH = 9 (0.1 M).
Gentamicin release
Gentamicin release was quantified dispersing conjugates (5 mg) in 1 ml of NaH2PO4 -Na2HPO4 buffer at pH = 7.4 and 5; the suspensions were kept in eppendorf and incubated at 37 °C. At prefixed times, samples were centrifuged and the supernatant collected for antibiotic quantification, the particles were resuspended in 1 ml of the corresponding buffer and incubated at 37 °C.
Gentamicin was quantified thorough fluorescence spectroscopy using o-phthaldialdehyde (OPA); 100 l of buffer containing antibiotic were mixed with 100 l of iso-propanol and 100 l of OPA reagent; after 30 min at room temperature in the dark, 200 l of the mixture were transferred in a black 96 wells plate and the fluorescence determined (excitation wavelength = 340 nm and emission wavelength = 450 nm) with a fluoroscan (FLUOROstar Optina, BMG Labtech); standards of known gentamicin concentration were also analysed simultaneously to provide calibration.
All characterisations were carried out on nanoparticles obtained from at least three independent batches; results are presented as mean ± standard deviation.
Results
The silica nanoparticles unconjugated (SiO2) appeared spherically shaped ( Figure 2 ) with a narrowly distributed diameter. The particles diameters population distribution was closely modelled by a Gaussian model with a mean of 55.5 nm and a standard deviation of 6.6 nm. Surface functionalisation, gentamicin conjugation or absorption along with LbL deposition did not have effect on these parameters (data not shown).
Examples of adsorption and desorption curves of nitrogen on the nanocarriers are presented in Figure 3 were differences between unfunctionalised nanoparticles and nanocarriers with entrapped gentamicin are evident. The BET parameters are summarised in Table 1 and revealed that the pore size of the particles was affected only by the entrapment of gentamicin. The functionalisation also resulted in a reduced BET surface area but further conjugation/adsorption did not affect either surface area or pores size of the nanocarriers.
During TGA analysis ( Figure 4 ) all particles exhibited a weight loss of about 8-10% in the temperature range 20-100 °C; with increasing temperature the weight loss of the samples increased monotonically reaching a plateau after about 600°C. Unfunctionalised and unloaded nanoparticles (SiO2) returned a weight loss of 14%. this was the lowest of all samples (Table 1) , whilst the nanocarriers with entrapped gentamicin had the greatest weight loss (31%). Nanoparticles loaded with gentamicin had the same mass loss regardless of the fact that the antibiotic was either conjugated or adsorbed; for both silica functionalised with amino groups (SiO2-NH2) or with carboxyl groups (SiO2-COOH), the weight loss increased when the nanocarriers were loaded with gentamicin, from 17 to 19 %.
The zeta potentials of the silica nanoparticles at pH values ranging from 4 to 9 are shown in Figure 5 ; in all cases the zeta potential decreased with increasing pH. Unfunctionalised nanocarriers had a negative charge throughout the pH range tested regardless of the presence of adsorbed gentamicin. Particles with entrapped antibiotic exhibited a slightly higher zeta potential than the corresponding unloaded nanocarriers. Amino functionalised silica nanoparticles had a remarkably high positive zeta potential (about +40 mV) at pH = 4 and 5; this decreased towards neutrality when pH increased to 7 and 9. The presence of gentamicin decreased the zeta potential compared to the unloaded particles with not significant differences between adsorbed or conjugated antibiotic at all pHs tested but 9. Silica nanoparticles functionalised with carboxyl acid groups had a positive zeta potential at pH = 4 while at more alkaline pH values the zeta potential was negative. The conjugation or adsorption of gentamicin resulted in higher zeta potential values through the pH range tested.
The percentage of gentamicin released from the nanocarriers over time in buffer at pH = 5 and 7.4 is shown in ( Figure 6 ). When gentamicin was entrapped in the silica nanoparticles, not all the antibiotic was able to leave and the release occurred in the first 4 hours, the maximum amount of gentamicin was higher at pH = 5 than at pH = 7.4. Unfunctionalised nanoparticles with adsorbed gentamicin released very little antibiotic in the first few hours and no more after this regardless of the pH tested. Functionalised silica nanoparticles both with amino and carboxyl groups exhibited a sustained release of antibiotic for at least 2 days. No significant difference was found between adsorption and conjugation method of loading gentamicin onto the nanocarriers. The kinetic of release was quicker at pH = 7.4 than at pH = 5.
During LbL deposition the organic content of the nanocarriers increased after each layer as shown by the TGA thermograms (Figure 7a ), additionally the surface charge initially positive became negative after the deposition of the alginate layers and positive after the deposition of chitosan ( Figure 7b ). After the deposition of gentamicin the surface charge was mildly positive. The release of antibiotics from silica nanocarriers prepared through LbL continued for 3 weeks and was affected by the pH of the solution (Figure 7b ).
Discussion
The Stöber synthetic method for silica nanoparticles is based on the hydrolysis of TEOS (soluble in water) in an water in oil emulsion; because of the nanoparticles growth occurs inside the water droplet, the final size and shape of synthesised nanoparticles depends on the size and shape of water droplets [44] . The variation of the organic solvent and of the other reaction conditions has been successfully employed to prepare silica nanoparticles in a wide range of sizes. Our results ( Figure 2) are consistent with other works employing the same reagents and conditions [48] ; furthermore the limited number of polyelectrolytes layers deposited onto the nanocarriers during LbL was no sufficient to increase the average particle diameter. Because of the mechanism of synthesis of the nanoparticles, entrapment of the antibiotic had no effect on size of the nanocarriers; however when gentamicin was present in the water phase, the growth of the silica particles was disturbed by the antibiotic resulting in nanoparticles with higher surface area (Table 1 and Figure 3 ). The adsorptiondesorption curves of N2 ( Figure 3 ) depict a typical Type II profile confirming the lack of mesopores in the nanocarriers. Furthermore, the lower amount of N2-adsorbed/desorbed by the nanocarriers with entrapped gentamicin compared to the other carriers, along with the lower values of total pore volume, suggests that the antibiotic is entangled inside the network of silane-oxygen bonds as suggested by Capeletti et al. [15] and Hakeem et al. [49] . Moreover, as gentamicin partitions predominately in the aqueous phase, the nanocarriers prepared through this protocol had the highest load of antibiotic. Similar loading results were reported for the encapsulation of vancomycin in mesoporous silica nanoparticles [15] . The functionalisation of the nanoparticles, the adsorption or conjugation of the antibiotic or the LbL deposition are processes affecting only the outer surface of the nanoparticles thus they did not impact the overall size and shape of the carriers. Likewise, these processes were also unable to impact the porosity of the nanoparticles, on the contrary they reduced the surface area of the nanocarriers available for gas adsorption as seen in the BET analysis (Table   1 and evidence has shown that positively nanoparticles have higher toxicity than negatively charged ones [45] . Human body pH is generally close to neutral, however there are some fluids that exhibit extreme acidity (stomach is about pH = 3.5 [46] ) or alkalinity (pancreatic fluid is about pH = 8.8 [47] ) therefore the pH range employed for our studies covers such spectrum. Unfunctionalised particles exhibit hydroxyl groups on the surface that behave as weak acid; hence they are protonated and nearly neutral at pH values up to about 7, while they are deprotonated, and with negative charge, in alkaline solutions. Amino groups are known to be protonated at alkaline pHs, while carboxylic acids are known to be protonated at pHs lower than 4-5 as the pKa of these compounds is about 4.5. Adsorption and conjugation of gentamicin was expected to reduce the number of carboxyl groups on the surface of the carriers available for dissociation thus reducing the number of negative charges; analogously for amino groups the conjugation or adsorption of antibiotic would interfere with the ability of the nitrogen to be protonated and such reducing the number of positive charges on the surface of the carriers. The pH dependence of the nanoparticles ( Figure 5 ) followed very well this description, providing further confirmation of the presence of either the desired groups or the antibiotic on the surface of the carriers.
Two different pH buffers were employed to study the release of gentamicin from the nanocarriers to mimic two distinct situations: prevention of infection represented by physiological (pH = 7.4) conditions and treatment of established infections represented by acid conditions (pH = 5) [50]- [52] . The release of gentamicin when entrapped into silica nanoparticles is not controlled as all the antibiotic that could be freed is released in the first hours of contact with aqueous solutions ( Figure   6 ); this is the consequence of the porosity of the nanocarriers that leads to water uptake. On the contrary, when gentamicin was adsorbed on unfunctionalised particles very little release was observed; at pH = 5 a greater amount of antibiotic was released from the particles than for pH = 7.4
indicating that the adsorption of gentamicin is more stable in neutral conditions. Interestingly, not all antibiotic loaded in the particles through entrapment could be released from the nanocarriers, this could have been caused by the ability of the antibiotic molecules to migrate through a limited distance inside the particles resulting in only the molecules present on the outer layers to be released. This is the mechanism hypothesised to explain why only about 10% of gentamicin mixed in bone cement is released over time [53] . However, because of the limited thickness of the particles compared to bone cement this justification seem unlikely; alternatively it can be hypothesised some of antibiotic loaded through entrapment is effectively adsorbed on the surface of the silica nanoparticles and our results show that desorption from these carriers is difficult. Furthermore, in all cases not all the antibiotic initial present on the silica nanoparticles was released ( Figure 6 ), even though not to the same extent as for the entrapped route; this seems to suggest that a certain amount of gentamicin can irreversibly bind to the silica surface. The higher adsorption of gentamicin onto silica at pH = 7.4 could also explain the lower total amount of antibiotic released from particles with entrapped antibiotic in this condition than in acidic environment.
Functionalised particles appeared more suitable for providing antibiotic release for at least few days, remarkably no difference was noticed between conjugation of the antibiotic or its adsorption.
Because the release from conjugated nanocarriers requires the hydrolysis of ester bonds, we expected that the kinetic of gentamicin release to be slower compared to the adsorption. Similar kinetic of release were reported from gentamicin conjugated onto the surface of functionalised gold nanoparticles through the formation of ester bonds [12] ; this points towards the controlling role of the type of bond on the release kinetic of conjugated antibiotic on surfaces. The functionalisation of the particles had an extreme impact on the loading and desorption of gentamicin, when either amino (positively charged) or carboxyl (negatively charged) were present on the surface more antibiotic was adsorbed onto the surface and the release of gentamicin was almost complete compared to about 10% seen in unfunctionalised silica nanoparticles. Gentamicin is charged as it exhibit amino and hydroxyl groups; the adsorption was carried out at pH = 6 were the functionalised nanoparticles possessed surface charges facilitating the electrostatic interaction between particles and antibiotic enhancing the amount of drug adsorbed compared to unfunctionalised molecules.
In this work, amino functionalised silica nanoparticles provided a positively charged substrate and we exploited the positive charge exhibited by gentamicin at physiological conditions, in virtue of the amino groups present on the molecule, to sandwich the antibiotic between alginate layers that are negatively charged. The choice of the polyelectrolytes used in this work (chitosan and alginate) was driven by the high biocompatibility of these biomacromolecules compared to other polyelectrolytes that are sometimes used for LbL i.e. poly(styrene sulfonate), poly(allylamine hydrochloride [54] and poly(diallyldimethyl ammonium chloride) [55] .
Drug release from LbL coating can occur either through diffusion of the molecule across the polyelectrolytes layers or as result of deposited layers erosion [56] , so called "delamination". These two mechanisms also control the shape of the release profile; if LbL erosion is governing the release, then the cumulative amount of drug unbound increases linearly over time until a plateau is reached, corresponding to full LbL consumption. When diffusion of the drug through the layers is the controlling mechanism, the cumulative amount of drug follows a Fickian profile instead [56] .
The release profile from our silica nanocarriers loaded through LbL (Figure 7c ) depicts a mechanism controlled by drug diffusion, this mechanism is also the likely reason for the similar release kinetics at pH = 5 and pH = 7.4 as the acidity of the solution does not influence the diffusion of the drug through the deposited polyelectrolytes layers. Furthermore, the need to cross the different deposited layers results in the prolonged release of gentamicin compared to the other nanocarriers prepared in this work where the antibiotic is freely available.
We have shown that silica nanocarriers loaded with gentamicin can be prepared through various protocols; depending on the preparation route, release of the drug can be tailored to different applications. For example, the complete release of the antibiotic in a few days appears suited for the treatment of local infections as it would allow the reduction of medications and thus improving patient compliance. On the other end, gentamicin release for many weeks is well suited for orthopaedic applications, such as encapsulation in bone cement. Because of the general nature of the phenomena employed in the preparation of our silica gentamicin nanocarriers (i.e. electrostatic forces and conjugation), it is easily foreseeable how the silica nanocarriers could be employed for the controlled delivery of other molecules.
Other types of antibiotic releasing silica nanoparticles have been proposed, however in some no attempt was made to determine the effective period of time that the drug was release [57] , [58] , whilst in others only one preparation protocol was presented hence the role of the protocol of synthesis in charactering the release was not established [59] .
It is well known that the current mixing of antibiotics in bone cement is released only for the first few days after surgery [60] , while infections can occur at the site even months after implantation [61] . Recently, antibiotics have been bound to silica nanocarriers either through conjugation [62] or co-precipitation [58] in order to provide controlled release. Despite the excellent blood compatibility and low toxicity demonstrated by these nanocarriers [62] , the release was sustained for about 1 week; hence not as effective as the nanocarriers presented in this work. LbL has also been used to prepare antibiotic loaded silica nanocarriers [63] , [64] . This approach was employed to entrap the drug under polyelectrolytes that enhance bacterial cell penetration [64] or to seal the drug inside mesoporous particles and, therefore, the polyelectrolytes acted as "gatekeeper" [49] ; in this way sustained the release for about 10 days was achieved [63] ; again not as effective as the nanocarriers presented in this work.
Mesoporous silica nanoparticles (MSN) have been widely investigated as drug delivery vehicles [65] - [69] with their main benefit compared to nonporous nanoparticles being the higher surface available for drug loading. When surface conjugation or adsorption is carried out, the drug release kinetics is unlikely to depend on the presence of pores and the conclusions of our study can be translated to mesoporous silica nanoparticles. When LbL is utilised as gatekeeping the released is delayed, instead of sustained, as the drug entrapped in the pores has to cross the layers in order to become available. As shown by Tamanna et al. [63] with increasing number of polyelectrolytes layers the concentration of antibiotic release tend to present a lag phase.
Nanocarriers based drug delivery systems for antibiotics require varying release kinetic according to the application they are design to fulfil; the desired release period can be from few days to weeks.
We have shown the versatility of silica nanoparticles to be prepared as antibiotic delivery system and correlated the preparation protocol to the chosen release kinetics specification.
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